Remepy
Pioneering Hybrid Drugs
StartupRemepy is a Ramat Gan-based startup in the Health Tech & Life Sciences sector, established in 2021. Pioneering Hybrid Drugs. The company has raised a total of $25M across 3 funding rounds, currently at the Seed stage. Remepy was founded by Or Shoval, Michal Tsur, Shahar Shelly. Key investors include NFX Capital, Vine Ventures, Psymed Ventures, among 9 total investors. The company has 51-200 employees. Core technologies: Platforms & Interfaces, Software.
With $25M in total funding, Remepy is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B/B2B2C business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageSeed
- ProductClinical Trial
- ModelB2B, B2B2C
- Employees51-200
- HQRamat Gan
- DistrictCenter District
- Last Round$10M
- NFX CapitalLead
- Vine Ventures
- Psymed Ventures
9 investors total
Or ShovalCo-founder & CEO
Michal TsurCo-founder & CEO
Shahar ShellyCo-founder & CMO
7 articles covered by sources including insights.citeline.com,
www.morningstar.com,
en.globes.co.il,
www.forbes.com,
www.calcalistech.com.
What does Remepy do?
Remepy is pioneering hybrid drugs, and redefining combination therapy. Its mission is to bring better personalized care to patients. Remepy’s Digital molecules are mobile applications designed for hybrid drug experiences, each containing a unique digital treatment protocol. Its Digital molecules include digitized, standardized, evidence-based interventions, designed to enhance brain plasticity and connectivity, balance the immune system, and drive behavioral changes. The company addresses disease end-points as well as side-effects and disease comorbidities. Remepy partners with pharma companies to bring Hybrid Drugs to market that will combine Remepy’s Digital Molecule and traditional drug components.
How much funding has Remepy raised?
Remepy has raised $25M in total funding across 3 rounds. The company is currently at the Seed stage. Key investors include NFX Capital, Vine Ventures, Psymed Ventures.
Who founded Remepy?
Remepy was founded in 2021 by Or Shoval (Co-founder & CEO), Michal Tsur (Co-founder & CEO), Shahar Shelly (Co-founder & CMO).
What sector is Remepy in?
Remepy operates in Health Tech & Life Sciences, Digital Healthcare, Medical Decision Support, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Platforms & Interfaces, Software. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is Remepy located?
Remepy is based in Ramat Gan, Israel, Center District.